The brochure describes the use of Tezspire, which is a drug used for the management of asthma. The drug is administered subcutaneously to treat severe asthma in children and adults. Asthma is an obstructive lung disease caused by exposure to allergens in predisposed individuals. In rare cases, asthma can be drug-induced through drugs such as Aspirin (Regnam & Richards, 2021). These three types of asthma; are extrinsic, intrinsic, and mixed types. The extrinsic type is the most common type, with childhood-onset and positive family history. The other two types are rare and are not caused by allergens. The brochure’s target audience is patients with a long history of asthma and their family and caregivers. It is written in a formal and straightforward language for the understanding of all parties. Patient education is a critical factor in the administration of drugs. The patient needs to know the full implication of the drug on the body and its primary purpose.
According to Dharmage et al. (2019), status asthmaticus, a severe form of asthma, has been a significant cause of death in patients with asthma. This drug has provided hope for these patients at the time of emergency. Moreover, the brochure provides the caregivers with information concerning the implication of administration of this drug with other drugs. Caregivers have a duty to educate their patients on drug administration and side effects. In most cases, caregivers omit essential information for the patients’ understanding during treatment. This brochure seeks to meet such objectives and compliments the caregivers’ effort to provide sufficient information on the use of Tezspire. The drug being new and effective, most physicians are likely to prescribe it to asthma patients. The brochure offers comprehensive information on the drug for the patient, family, and caregivers.
References
Dharmage, S. C., Perret, J. L., & Custovic, A. (2019). Epidemiology of asthma in children and adults. Frontiers in Pediatrics, 7(246). Web.
Regnam, D., & Richards, S. (2021). Tezspire in management of asthma. Medlineplus.gov. Web.